News
Trump, Pharma and high tariffs
Digest more
Johnson & Johnson shrugs off tariff impact
Digest more
Bloomberg on MSN6h
Novartis CEO on Psoriasis Drug, China Growth, Tariffs, M&ANovartis AG announced disappointing sales for a key psoriasis drug and the looming retirement of its respected finance chief, ...
President Trump has flagged that US tariffs on pharmaceutical imports are likely to kick in on Aug. 1, with duties on ...
Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...
President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.
In its Q2 earnings call Thursday, Novartis said it is moving quickly to reshore its drug manufacturing operations, but CEO ...
President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a "low ...
Additional threat certain to alarm Government already working with EU to reduce impact of threatened 30% general tariff on ...
At a Cabinet meeting earlier this month, Trump said that he expected pharmaceutical tariffs to grow as high as 200% after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback